uniQure N.V. - Ordinary Shares

QURE 
(NASDAQ) 
 
$ 69.61 <%= Resources.Global.txtDown %>
Updated 15/07/2019
Change % -0.06% Stock price decreasing
Change -0.04 Stock price decreasing
Volume 233,722
High $ 71.00
Low $ 68.74
Open $ 69.68
ISIN
Prev close $ 69.65
# of shares 37.80M
Market cap 2,631.20M USD
Intraday

Market closed
uniQure N.V. - Ordinary Shares
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  69.61 -0.9% Stock price decreasing -14.2% Stock price decreasing 27.4% Stock price increasing 122.9% Stock price increasing 90.2% Stock price increasing
Powered by TradingView

News about uniQure N.V. - Ordinary Shares

  • English
  • Regulatory news

Company profile

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 July 2019 02:12:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB6 - 2019-07-17 03:12:25 - 2019-07-17 02:12:25 - 1000 - Website: OKAY